Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07018622
What this trial is testing

Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity

Who this might be right for
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 46
Post-approval studies (Phase 4)Study completedNCT05621551
What this trial is testing

Dapagliflozin Therapy In Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
China National Center for Cardiovascular Diseases 178
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableStudy completedNCT05966792
What this trial is testing

SGLT2 Inhibitors in Treating Patients With PCOS

Who this might be right for
Polycystic Ovary Syndrome
Shanghai 10th People's Hospital 82
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Large-scale testing (Phase 3)UnknownNCT05162690
What this trial is testing

Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy

Who this might be right for
Diabetic Peripheral Neuropathy
Post Graduate Institute of Medical Education and Research, Chandigarh 40
Not applicableStudy completedNCT05640180
What this trial is testing

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Bayer 17,847
Not applicableActive Not RecruitingNCT07602348
What this trial is testing

Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

Who this might be right for
Diabetic RetinopathyGLP-1SGLT 2 Inhibitors+3 more
University of Athens 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Not applicableLooking for participantsNCT06473844
What this trial is testing

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Who this might be right for
SepsisInflammationSGLT2 Inhibitors+2 more
Hospital Authority, Hong Kong 60
Not applicableUnknownNCT05520684
What this trial is testing

Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk

Who this might be right for
Type2diabetes, SGLT2 Inhibitor, Urinary Tract Infection
Trabzon Arakli Bayram Halil Public Hospital 120
Post-approval studies (Phase 4)UnknownNCT03433248
What this trial is testing

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

Who this might be right for
Type2 Diabetes
M.H.H. Kramer 66
Large-scale testing (Phase 3)Study completedNCT03151343
What this trial is testing

SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk

Who this might be right for
Type2 Diabetes Mellitus
Caroline M Kistorp 92
Not applicableStudy completedNCT02966626
What this trial is testing

A Real World Experience of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Type2 Diabetes
University of Malaya 223
Not applicableStudy completedNCT07465926
What this trial is testing

Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

Who this might be right for
Cardiovascular-kidney-metabolic SyndromeCardiovascular Disease Risk FactorKidney Disease+2 more
Chung Shan Medical University 451,036
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Post-approval studies (Phase 4)Study completedNCT05278962
What this trial is testing

HF Patients With LVADs Being Treated With SGLT2i

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of Chicago 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749014
What this trial is testing

Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients

Who this might be right for
ST-elevation Myocardial Infarction (STEMI)Acute Myocardial Infarction (AMI)Coronary Artery Disease
Rehman Medical Institute - RMI 480
Not applicableNot Yet RecruitingNCT07580638
What this trial is testing

Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 3,550
Not applicableStudy completedNCT07566299
What this trial is testing

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Obesity Type 2 Diabetes MellitusCardiovascular-kidney-metabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease
Chung Shan Medical University 118,805
Next Page